EXTREME PREMATURITY
Clinical trials for EXTREME PREMATURITY explained in plain language.
Never miss a new study
Get alerted when new EXTREME PREMATURITY trials appear
Sign up with your email to follow new studies for EXTREME PREMATURITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common anemia drug shield preemie brains from damage?
Disease control CompletedThis large Phase 3 trial tested whether giving erythropoietin (Epo) to extremely premature infants within 24 hours of birth could reduce death or severe neurodevelopmental problems. Over 900 babies born between 24 and 27 weeks of pregnancy were enrolled. The study compared Epo in…
Matched conditions: EXTREME PREMATURITY
Phase: PHASE3 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
Could a common painkiller help preterm Babies' hearts?
Disease control CompletedThis study tested whether giving acetaminophen (paracetamol) early after birth can help close a blood vessel (ductus arteriosus) that often stays open in extremely preterm infants. Over 800 babies born between 23 and 28 weeks of pregnancy took part across Europe. The goal was to …
Matched conditions: EXTREME PREMATURITY
Phase: PHASE2, PHASE3 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 23, 2026 11:54 UTC
-
Do early antibiotics harm fragile preemies? new study investigates
Disease control CompletedThis study looked at whether giving antibiotics early to extremely low birthweight babies (under 3.3 pounds) might cause more problems than it prevents. Researchers compared babies who got standard antibiotics in the first week of life to those who got a placebo. The goal was to …
Matched conditions: EXTREME PREMATURITY
Phase: PHASE4 • Sponsor: Michael Morowitz • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
New technique may spare tiniest babies from breathing tubes
Disease control CompletedThis study tested a method called LISA (Less Invasive Surfactant Administration) in extremely preterm infants (22-25 weeks). Instead of inserting a breathing tube, doctors gave lung medication through a thin catheter while the baby continued on CPAP. The goal was to see if this a…
Matched conditions: EXTREME PREMATURITY
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC